Abstract:Background: Heart failure (HF) is an epidemic disease with increased incidence annually. It has been reported that taurine can improve cardiac function. This study investigated the cardioprotective effects of taurine in pressure-loaded HF mice and elucidated the possible mechanism. Methods: HF models were established by transverse aortic constriction (TAC). Animals were treated with either taurine for 9 weeks and/or the SIRT1 inhibitor EX527 (5 mg/kg/day, every 2days) after TAC operation. Cardiac function and geometry were revealed by echocardiography. Myocardial hypertrophy and fibrosis were assessed using Fluorescent wheat germ agglutinin (WGA) staining and Masson's trichrome staining. Western blot and RTPCR were performed to elucidate the expression of target proteins and genes respectively. Apoptosis in cardiomyocytes was detected by TUNEL staining. Myocardial oxidative stress was assessed by detecting the concentration of myocardial super oxidative dismutase (SOD) and malonyldialdehyde (MDA) and reactive oxygen species (ROS). Taurine concentrations and NAD+/NADH ratio were determined by taurine and NAD+/NADH assay kit. Results: Taurine notably relieved cardiac dysfunction after TAC. The mechanisms were attributed to reduced myocyte hypertrophy and fibrosis, and alleviated apoptosis and oxidative stress. Meanwhile, taurine increased NAD+/NADH ratio,promoted the expression of SIRT1 and suppressed p53 acetylation. However, EX-527(in-hibitor of SIRT1) decreased NAD+/NADH ratio and increased acetyl-p53 levels, and abolished the cardioprotective effects of taurine on mice subjected to TAC and increased apoptosis and oxidative stress. Conclusion: The mechanism responsible for cardiac-protective effects of taurine in HF induced by pressure overload is associated with the activation of the SIRT1-p53 pathway.

Influence of Taurine on Expression Level of Hypoxia Induction Factor-1Α in Hypoxia-Injured Rat Cardiac Myocytes

Effect of Taurine on Primary Cultured Neonatal Rat Myocardial Cells and Cardiac Fibroblasts

Low-dose Taurine Upregulates Taurine Transporter Expression in Acute Myocardial Ischemia.

Effects of taurine on intracellular free calcium concentration of cultured neonatal rat cardiomyocytes during hypo-xia/reoxygenation

Protective Roles and Mechanisms of Taurine on Myocardial Hypoxia/Reoxygenation-Induced Apoptosis.

Effects of Taurine on Apoptosis in Cultured Neonatal Rat Cardiomyocytes Induced by Simulated Ischemia-Reperfusion

Effects of Taurine on Apoptosis in Neonatal Rat Cardiomyocytes Induced by Exogenous Hydroxyl Free Radical

Effect of Taurine on the Respiration Enzymes of Myocardial Mitochondria Injured by Ischemia-Reperfusion in Rats

Taurine Protects Against Cardiac Dysfunction Induced by Pressure Overload Through SIRT1–p53 Activation

Effects of Taurime on Expression of Bcl-2 and Bax Proteins in the Ischemic Myocardium of the Rats

Neuroprotective Actions of Taurine on Hypoxic-Ischemic Brain Damage in Neonatal Rats

Effects of Taurine on Plasma Cardiac Troponin T Levels and Myocardial GRP78 and Caspase-12 Expression in Rats Undergoing Ischemia-Reperfusion

Protective effects of taurine on LPS-induced myocardial damage in rats

Taurine Protects Primary Neonatal Cardiomyocytes Against Apoptosis Induced By Hydrogen Peroxide

The Effects of Taurine on Myocardial Cells Apoptosis in the Rats with Renovascular Hypertension

Effects of taurine on newborn with hypoxic ischemic myocardial injury following asphyxia

Protective effects of taurine to ischemic re-injury on ischemic myocardium in rat

Effect of Taurine on the Expression of Nestin in Neural Stem Cell after Focal Cerebral Ischemia in Rats

The Effects of Taurine on Injury of Myocardial Mitochondria in Rats after Exhaustive Exercise

Dysfunction of Myocardial Taurine Transport and Effect of Taurine Supplement in Rats with Isoproterenol-Induced Myocardial Injury.

Effect of Taurine on the Synthesis of Collagen, Proliferation of Cardiac Fibroblasts and the Expression of TGF-β1